Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech SPDR (NY: XBI )

88.21 +0.09 (+0.10%)
Official Closing Price Updated: 8:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,099,708
Open 88.15
Bid (Size) 88.11 (12)
Ask (Size) 88.36 (3)
Prev. Close 88.12
Today's Range 87.01 - 88.89
52wk Range 62.13 - 95.17
Shares Outstanding 750,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Market Mixes It Up With A Broad Rally
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive. 
Via Talk Markets
“Skip Or Flip” Stock Market (And Sentiment Results)
We are at the cusp of a sea change, and the knock-on effects will be material. We expect to see two meaningful changes in the coming months as a result of the Fed being done. 
Via Talk Markets

Performance

YTD
+8.19%
+8.19%
1 Month
+3.78%
+3.78%
3 Month
+8.59%
+8.59%
6 Month
+8.78%
+8.78%
1 Year
+21.50%
+21.50%

More News

Read More
A Good Week For The Market But A Pause In The Biotech Rally
Via Talk Markets
The Dierks Bentley “Feels Like Gold” Stock Market (And Sentiment Results)
Via Talk Markets
Why These 3 Nasdaq Stocks Buckled Today
Via The Motley Fool
Time To Play Small Cap Life Science Stocks
Via Talk Markets
Biotech ETFs Pop On M&A Resurgence
Via Talk Markets
Something Happened In Biotech Last Week
Via Talk Markets
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
Via Talk Markets
Second Quarter Outlook For Biotech Stocks
Via Talk Markets
“Knockin’ On Heaven’s Door” Stock Market (And Sentiment Results)
Via Talk Markets
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
Via Benzinga
Thermo Fisher, Principal Financial Group, And Two Promising ETFs Steal The Show On CNBC's 'Final Trades'
Via Benzinga
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Via Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Via Benzinga
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Via Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Via Benzinga
Time to Spring-Clean...Your Stock Portfolio
Via The Motley Fool
April Is Busting Out For Healthcare And Biotech
Via Talk Markets
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Via Benzinga
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags
Via Talk Markets
The Stock Market Rally May Fizzle The Week Of April 3
Via Talk Markets
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
Via Talk Markets
“Don’t Stop Believin'” Stock Market (And Sentiment Results)
Via Talk Markets
This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.